Horizon Pharma plc to Participate in Cowen and Company 37th Annual Health Care Conference

DUBLIN, Ireland, Feb. 14, 2017 -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will present at the Cowen and Company 37^th Annual Health Care Conference at 2:40 p.m. ET on March 6, 2017 in Boston, MA.

The conference presentation will be webcast live and may be accessed by visiting Horizon's investor relations section of the website at http://ir.horizon-pharma.com.  A replay of the webcast will be available for the event.

About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs.  The Company markets 11 medicines through its orphan, rheumatology and primary care business units.  For more information, please visit www.horizonpharma.com.  Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

Contacts:

Tina Ventura
Senior Vice President, Investor Relations
[email protected] 

U.S. Media:
Geoff Curtis
Senior Vice President, Corporate Communications 
[email protected]

Ireland Media:
Ray Gordon
Gordon MRM 	
[email protected]